Masahiro Yasunaga

13PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMolecular targetsAcceleratorsCancer therapy (excl. chemotherapy and radiation therapy)Industrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 28, 2026
Potent antitumor efficacy of datopotamab deruxtecan compared with sacituzumab govitecan in an intracranial tumor model of triple-negative breast cancer.

|May 16, 2026
Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis.

|Mar 01, 2026
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 Radioimmunotherapy.

Hiroki Takashima, Ryo Tsumura, Yoshikatsu Koga

|Oct 01, 2025
Near-Infrared Photoimmunotherapy Targeting Esophagogastric Junction Adenocarcinoma With Fully Human Anti-EpCAM Antibody.

Maasa Sasabe, Kenji Takashima, Shingo Sakashita

|Oct 25, 2024
Potential Mechanisms of Interstitial Lung Disease Induced by Antibody-Drug Conjugates Based on Quantitative Analysis of Drug Distribution.

Shigehiro Koganemaru, Hirobumi Fuchigami, Chihiro Morizono

|Sep 25, 2024
Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models.

Ryo Tsumura, Takahiro Anzai, Yoshikatsu Koga

Pageof 3

Frequent Collaborators

7 joint publications

Hiroki Takashima

5 joint publications

Shino Manabe

3 joint publications

Yoshikatsu Koga

2 joint publications

Ryo Tsumura